| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.1 | 0.08 |